Loftus, Edward V. Jr.
Griffith, Jenny
Neimark, Ezequiel
Song, Alexandra
Wallace, Kori
Nannapaneni, Sujani
Zhou, Ji
Byrne, Rachel
Kligys, Kristina
Pang, Yinuo
Liao, Xiaomei
Kalabic, Jasmina
Dubinsky, Marla
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
https://doi.org/10.1007/s12325-023-02477-2
Funding for this research was provided by:
AbbVie
Article History
Received: 23 January 2023
Accepted: 20 February 2023
First Online: 14 March 2023